Tag Archives: Neuropsychopharmacology and Brain Imaging Research Unit

Psychiatrists have come up with a ‘solution’ to psychiatric drugs—prescribe LSD, animal tranquilizers & mushrooms

Low doses of psychedelic drugs, including lysergic acid diethylamide (LSD), ketamine, and psilocybin, may reduce clinical symptoms in patients with depression, anxiety, obsession-compulsive disorders (OCDs), and chronic pain, without inducing depersonalization or hallucinations, according to a new Perspectives article published online August 18 in Nature Reviews Neuroscience.